Spanish for cardiology clinic nurses: the patient who stopped his beta-blocker because it made him tired and did not know what would happen to his heart rate, the patient with atrial fibrillation who stopped her anticoagulant after a shaving cut terrified her, and the patient who has been skipping his diuretic on errand days because he cannot find a bathroom

2026-07-04 · ~28 min read · ClinicaLingo blog

Miguel Herrera had been tired for three months. Not tired the way a person is tired after a long shift — tired the way his arms felt underwater, the way climbing the stairs to his apartment on the second floor made him stop on the landing and put his hand on the wall, the way he had given up the Saturday morning walk to the park with his neighbor Ernesto because by the time he got to the corner his legs were already heavy.

He was fifty-eight years old, a retired bus driver from Los Angeles. He had driven the number 720 along Wilshire for twenty-two years, and for most of those years he had been the kind of man who walked to work when the bus depot was close enough. He had been put on a beta-blocker nine months ago after a cardiology workup found hypertension and a stress test found ST changes consistent with stable angina. The cardiologist had started him on carvedilol 12.5 milligrams twice daily. Miguel had taken it faithfully for six months.

Then he had stopped.

He had not called the clinic. He had not mentioned it at his last visit three months ago, when the nurse had asked him how he was and he had said “bien, bien” and the appointment had been brief and efficient. He had stopped because the tiredness had started within two weeks of the first dose and had never fully lifted, and he had looked up the medication online and read that fatigue was a side effect, and after six months of feeling like a slower version of himself he had decided the slower version was not acceptable and had left the bottle in the cabinet.

He had felt better almost immediately. More energy. The stairs were easier. He had started the walks with Ernesto again. He had thought he had made the right call.

Last week, twice, climbing the stairs with groceries, he had felt something in his chest. A tightening. Both times it had passed in a few minutes when he sat down. He had attributed it to the July heat.

Three outpatient cardiology patterns that arrive in the waiting room as “me sentía mejor sin él” and “me corté y no paró de sangrar y creí que me iba a morir” and “no la tomo los días que tengo mandados porque no encuentro baño”: Miguel Herrera, fifty-eight, a retired bus driver from Los Angeles with stable angina who stopped carvedilol six weeks ago because the fatigue was making his life smaller, whose blood pressure is 158 over 96 today and whose heart rate is 94, and who has had two episodes of chest tightness on the stairs in the past week that started after he stopped the medication and that he is attributing to the summer heat; Rosa Mendoza, seventy-two, a retired seamstress from San Diego with atrial fibrillation who stopped apixaban eight weeks ago after she cut herself shaving her legs and pressed a washcloth against the shin for twenty-five minutes and was convinced she was going to bleed to death, who has not told her cardiologist or anyone on the care team; and Jorge Cisneros, sixty-four, a retired construction foreman from Phoenix with heart failure and an ejection fraction of 35 percent, on furosemide 40 milligrams daily, who has been skipping the diuretic two or three days per week on any day involving errands, medical appointments, or outings where bathroom access is uncertain, arriving today with two-plus bilateral ankle edema and four pounds above his dry weight.

The patient who stopped his beta-blocker because it made him feel tired and has had two episodes of chest tightness on the stairs since stopping

The intake nurse took Miguel’s blood pressure: 158 over 96. She checked the chart. Nine months ago, on carvedilol, his blood pressure had been running 128 over 82. Heart rate: 94. Nine months ago it had been 62.

She looked at the medication list. Carvedilol 12.5 mg twice daily. Lisinopril 10 mg daily. Aspirin 81 mg daily. Three medications on the list.

“Señor Herrera, quiero revisar sus medicamentos. El carvedilol — ¿lo ha tomado con regularidad?”

There was a pause.

“Mire, la verdad es que lo dejé hace como seis semanas.”

“¿Puede contarme por qué?”

He explained the fatigue. The stairs. The walks he had given up. The six months of feeling like a slower version of himself. The online search that confirmed it was a side effect. The decision to stop.

“Ese cansancio que describió — que se sentía más lento, que las piernas no respondían bien — ese efecto es real. No se lo estaba imaginando. Y entiendo por qué lo dejó. Seis meses sin poder caminar normal es mucho tiempo.”

She acknowledged it first. Then she explained the mechanism.

“El betabloqueador reduce la velocidad del corazón y la fuerza con la que late — eso es lo que hace: es el objetivo del medicamento. Pero los mismos receptores que están en el corazón también están en los músculos del cuerpo. Cuando el medicamento los bloquea, los músculos reciben menos estímulo del sistema nervioso, y eso se siente como cansancio. En algunas personas ese efecto se reduce con el tiempo; en otras, cambiando a un tipo diferente de betabloqueador — uno que sea más específico para el corazón — el cansancio mejora mucho. Hay opciones que no exploreó todavía.”

Then she named the rebound.

“Hay algo importante que quiero contarle sobre lo que pasa cuando se para el betabloqueador de repente. El corazón se había acostumbrado al medicamento — había ajustado sus receptores para funcionar con el bloqueo presente. Cuando el medicamento se retira rápido, esos receptores reaccionan: la frecuencia cardíaca sube, la presión sube, y en personas que tienen angina — el dolor de pecho que usted tuvo antes, que fue lo que llevó al estudio — a veces eso puede hacer que la angina regrese. Se llama efecto de rebote.”

Miguel was quiet.

“Y quiero preguntarle algo. Desde que dejó el medicamento, ¿ha notado algo diferente en el pecho — aunque sea leve, aunque haya durado poco?”

He mentioned the stairs. The tightening. Twice last week. He had not connected it to stopping the carvedilol. He had thought it was the July heat.

“Esos episodios — ¿cuánto le duraron? ¿Le pasaron también en el brazo izquierdo o en la mandíbula? ¿Se le quitó cuando se sentó?”

Two to three minutes each time. No radiation. Resolved with rest. Both times on the stairs, both times with exertion. It had not happened at rest. The nurse wrote it all down and flagged it for the cardiologist before the visit.

The cardiologist reviewed the strip, the vitals, and the symptom history. The pattern was consistent with rebound angina: exertional chest tightness beginning approximately two weeks after stopping a beta-blocker in a patient with known stable angina and prior ST changes on stress testing. The plan: restart a cardiac-selective beta-blocker — bisoprolol 5 milligrams once daily, more cardioselective than carvedilol, once-daily dosing, and a shorter half-life during initial titration — with a four-week call-in follow-up to assess the fatigue. If fatigue persisted, dose adjustment was possible. If the chest symptoms did not fully resolve within two weeks, a repeat stress test would be ordered.

The nurse explained bisoprolol before Miguel left.

“Este betabloqueador es diferente al que tenía. Es más específico para el corazón — bloquea menos los músculos del cuerpo. Se toma una vez al día en vez de dos. Muchas personas que tuvieron el cansancio con carvedilol lo toleran mejor. Y si en cuatro semanas sigue con cansancio que le molesta, llame a la clínica — hay ajuste de dosis. No lo deje sin llamarnos primero.”

At four weeks, Miguel called. The fatigue was present but had improved substantially from the carvedilol months. He had not had any chest tightness since restarting. His heart rate at the call-in check was 61. Blood pressure 131 over 82.

At three months, he was walking with Ernesto on Saturday mornings again. He had not had a chest tightening episode since week two after restarting.

“El cansancio sigue un poco,” he said at the three-month visit. “Pero ya no es lo que era. Y cuando me dijo lo del rebote — los dos episodios en las escaleras justo después de dejar el medicamento — eso sí me impresionó. No había hecho la conexión.”

He had not made the connection because nobody had told him to expect it. The carvedilol label says “do not stop without consulting your doctor.” Miguel’s discharge instructions had that language in English and he had a copy somewhere in a folder at home. But when the fatigue became a quality-of-life problem, the label’s warning was not the thing he was thinking about. The nurse who asked whether he had noticed anything different in his chest since stopping was the person who found the rebound angina before it became something more.

The patient with atrial fibrillation who stopped her anticoagulant after a shaving cut frightened her and has not told anyone for eight weeks

Rosa Mendoza was seventy-two years old and she had been on apixaban for three years. Her atrial fibrillation had been diagnosed at sixty-eight after a Holter monitor caught the irregular rhythm her primary care doctor had heard on auscultation and suspected but could not pin down at a regular visit. Her cardiologist had calculated her stroke risk, explained that the number was high enough to recommend anticoagulation, and started her on apixaban 5 milligrams twice daily.

She had taken it faithfully for three years. She had been careful about falls. She had stopped taking aspirin because the cardiologist said not to combine them without specific reason. She had told the dentist before her tooth extraction. She had done everything she had been told.

Eight weeks ago, on a Sunday morning, she had cut herself shaving her legs. Not a deep cut — the razor had caught the skin just above the ankle. She had pressed a washcloth against it. It had not stopped. She had pressed harder. Five minutes, ten minutes, fifteen minutes. At twenty-five minutes she had been trembling and had called her daughter who lived across town. Her daughter had arrived at twenty-eight minutes and had sat with her on the bathroom floor and pressed the washcloth and at thirty-two minutes the bleeding had stopped.

Rosa had not gone to the emergency room. There had been no wound that needed stitches — the cut was small, a surface nick. But she had sat on the bathroom floor for thirty-two minutes believing she was going to bleed to death, and when it stopped, she had walked to the cabinet, taken out the apixaban, and put the bottle in the back of the drawer under the hand towels.

She had not told the cardiologist. She had not told the clinic nurse. She had come to her follow-up visit four weeks later and the intake nurse had asked how she was doing and she had said fine, well, the usual, and when the nurse had asked about medications she had said yes, she was taking them. She had not said it was a lie, exactly. She had said yes and felt the shape of what she was not saying and had told herself she would find the right moment to bring it up and had not.

Today was the next appointment, eight weeks after the shaving incident.

The intake nurse took the medication history. When she reached apixaban, she asked — not as a rote question, but as a specific one, because she had noticed at Rosa’s last visit that the refill cycle was slightly off by two weeks:

“Señora Mendoza, quiero preguntarle específicamente sobre la apixabán — ¿ha habido alguna semana en que haya sido difícil tomarla, o en que haya dejado de hacerlo por algún motivo?”

There was a long pause.

“La dejé hace ocho semanas. Desde que me corté afeitándome.”

She told the nurse everything. The washcloth. The thirty-two minutes. Her daughter on the bathroom floor. The terror of watching the blood not stop.

The nurse did not say “tenía que haberme llamado” and did not say “no debe dejarlo, es muy importante.” She said:

“Treinta y dos minutos sangrando en el piso del baño es aterrador. Que haya llegado su hija y que hayan estado juntas — eso fue lo correcto. Entiendo completamente por qué guardó el frasco. Y entiendo por qué fue difícil decirlo en la última cita. Gracias por contármelo hoy. Quiero explicarle lo que pasó, porque lo que le pasó tiene una explicación que no es que usted se esté desangrando.”

The mechanism: apixaban slows the clotting cascade — specifically, it inhibits Factor Xa, one of the enzymes involved in forming a clot. When you cut yourself, the cascade starts, but it runs more slowly. A cut that would normally stop bleeding in three to five minutes may take fifteen to thirty minutes when you are on a direct oral anticoagulant. This is the intended effect: the same mechanism that stops you from clotting too quickly in your heart also slows the clotting at the surface of a skin cut. The cut does not bleed more deeply. It does not spread internally. And a small razor nick — in a person with no underlying bleeding disorder — will stop with firm pressure. The error is checking every two minutes (which disrupts the clot forming at the surface) and moving the washcloth. Firm pressure for ten to fifteen minutes without lifting, without checking, and without panicking is the protocol.

“Lo que pasó con la navaja fue real — tardó mucho, fue muy asustador, y nadie le había dicho que eso podía pasar. Eso es una falla nuestra, no suya. El medicamento hace lo que debe hacer: va más lento con los cóagulos. Y una cortada pequeña en la piel con presión firme sostenida sin levantar el paño — por quince minutos, sin revisar — para. Usted lo experimentó: a los treinta y dos minutos paró. La próxima vez, con la técnica correcta, parará antes.”

Then the nurse explained what the apixaban was protecting Rosa from.

“La fibrilación auricular — el ritmo del corazón que usted tiene — hace que la sangre en las cámaras del corazón no se mueva de manera uniforme. En ese movimiento irregular, a veces se forman cóagulos. Si un cóagulo sale del corazón y llega al cerebro a través de la sangre, puede causar una apoplexía — un derrame. Los derrames por fibrilación auricular a veces llegan sin aviso: una persona se despierta sin poder mover el brazo derecho, o sin poder hablar. La apixabán reduce ese riesgo en más de dos tercios. En su caso específico — con su edad, su historial, su presión — ese riesgo sin el medicamento es real. Lo que pasó con la navaja es real. Son dos cosas diferentes en escala.”

Rosa was quiet for a moment.

“¿Cuánto tiempo llevo sin la protección?”

“Ocho semanas.”

She restarted the apixaban that day. The nurse printed a wound-care card in Spanish before she left: firm pressure without lifting for fifteen minutes on any surface cut; elevation if on the leg; if bleeding has not slowed at all after twenty minutes of uninterrupted pressure, call the clinic; if dizziness, confusion, significant bruising without cause, or blood in the urine, call immediately.

In the three months after that appointment, Rosa cut herself shaving twice. Both times she followed the protocol. The first took fourteen minutes. The second took nine. Neither required a phone call.

“El miedo que tuve esa noche era real,” she said at the six-month follow-up. “Lo que no sabía era que el miedo y el riesgo no eran iguales. Me hubiera gustado tener ese papel desde el principio.”

She was right. A wound-care card with the expected bleeding time and the pressure protocol — printed in Spanish, handed at the visit when anticoagulation was started — would have been the piece of preparation that prevented eight weeks without stroke protection. It is a five-minute add to the anticoagulation initiation visit. The cardiology clinic updated its discharge checklist the week after Rosa’s appointment.

The patient who has been skipping his diuretic on days he has errands because he cannot count on finding a bathroom and does not think skipping two or three days a week matters that much

Jorge Cisneros came in for his eight-week heart failure clinic follow-up and the intake nurse weighed him. He was four pounds above his dry weight. She checked his ankles: two-plus bilateral pitting edema. She asked when this had started.

“Llevo unas semanas así. Los tobillos se ponen un poco y se les va. Esta semana están más.”

She looked at his medication list. Furosemide 40 mg daily. Lisinopril 5 mg daily. Carvedilol 6.25 mg twice daily.

“El furosemide — la pastilla del agua — ¿lo ha tomado todos los días?”

“La mayoría. Me la salto algunos días.”

“Enténdame bien — quiero asegurarme de que entiendo. ¿Cuántos días a la semana, más o menos? ¿Y puede contarme cuáles días son?”

Two or three days per week. The days with the grocery store. The days with doctor appointments across town. The day he had gone to his grandson’s school presentation. Any day when he was not going to be at home, where he knew the bathroom was twenty feet from any chair in the house and there was no urgency about timing.

“Cuando la tomo tengo que ir al baño varias veces en las primeras tres o cuatro horas. En la casa, no hay problema. Afuera — no sé dónde está el baño, si está cerrado, si hay que esperar, si llego a tiempo. Me pone ansioso. Así que los días que salgo, no la tomo.”

“Entiendo. Eso tiene mucho sentido — no quiere que el medicamento lo ponga en una situación incómoda cuando está afuera. Quiero hablarle de dos cosas. La primera es sobre el horario — porque puede haber una forma de ajustarlo. La segunda es sobre lo que pasa con el líquido los días que no toma la pastilla, porque creo que es diferente a lo que uno se imaginaría.”

She asked what time Jorge usually took his furosemide on the days he did take it.

“A veces en la mañana, a veces a mediodía. Depende cuándo me acuerdo.”

“¿Y a qué hora normalmente hace sus mandados?”

“Por la mañana, generalmente. Me gusta ir temprano antes de que haga mucho calor.”

“Aquí hay algo que podría funcionar. El furosemide trabaja rápido: en una hora ya está haciendo efecto, y en cuatro a seis horas ya pasó lo más intenso. Si usted lo toma a las siete de la mañana, para las once o el mediodía el efecto más fuerte ya pasó. Si sus mandados son por la tarde — o si puede salir después del mediodía — ya no tendría la urgencia que lo preocupa. ¿Hay forma de organizar sus salidas por la tarde?”

Jorge thought about it. Some of his errands were flexible. The pharmacy was open until nine. The supermarket was open until ten. His daughter’s school presentation had been at four in the afternoon. If he had taken the furosemide at seven AM, the peak would have passed by eleven.

“Algunos sí. No todos.”

“Para los que no puede mover, hay otra cosa. ¿Hay una farmacia, un Walmart, una gasolinera grande en el camino a los lugares que va? La mayoría de esos lugares tienen baños accesibles. No tiene que saber si va a necesitarlos — pero si sabe que el baño está ahí si lo necesita, ¿eso le quitaría la ansiedad?”

It might, Jorge said.

Then the nurse explained the fluid accumulation model, because Jorge needed to understand why the current pattern had produced four pounds above dry weight.

“El furosemide le hace a los riñones eliminar el líquido extra por la orina. Funciona por el tiempo que está activo en su cuerpo — unas seis a ocho horas después de tomarlo. Los días que no lo toma, los riñones retienen el líquido que hubieran eliminado. Ese líquido no desaparece al día siguiente cuando toma la pastilla — las dosis del resto de la semana eliminan el líquido del día que las toma, pero no compensan completamente los días saltados. Si salta dos o tres veces a la semana, el líquido se acumula. Los tobillos que tiene hoy son ese líquido — cuatro libras de líquido que no salió en las semanas pasadas.”

“¿Y si lo sigo saltando?”

“Con su corazón — la fracción de eyección del 35 por ciento significa que el corazón está bombeando menos eficientemente de lo normal. Cuando hay líquido extra, el corazón tiene que trabajar más. Cuando trabaja más con esa eficiencia reducida, puede llegar un punto en que los pulmones empiezan a acumular líquido también — eso produce dificultad para respirar, especialmente al acostarse. Ese es el camino hacia una hospitalización. No estamos ahí hoy. Pero los cuatro libras de hoy son la señal de que el patrón actual no está funcionando para su corazón.”

“¿Por qué nadie me preguntó por qué la dejaba? Lo hubiera dicho.”

The nurse made a note in the chart: patient had been skipping furosemide on errand days due to bathroom access concern; plan implemented for 7 AM fixed dosing with errand scheduling after peak diuresis; patient identified two pharmacy locations on common errand routes; patient verbalized understanding of fluid accumulation mechanism; repeat weight in two weeks.

Jorge left with a 7 AM medication alarm set on his phone, a note in the visit summary about taking furosemide before his morning shower and before planning his day, and the name of a CVS on his usual supermarket route that had a bathroom near the pharmacy counter.

Two weeks later, he called to report his home weight: one pound above dry weight. Ankle edema mild on palpation at the check-in. Four weeks after that, at the next scheduled visit: weight at dry weight. No ankle edema. He had not missed a dose in six weeks.

“Lo del baño seguía siendo el problema,” he told the nurse. “Pero ahora ya sé dónde está en cada lugar que voy. Y a las once ya no me urge tanto. El problema no era la pastilla — era el baño. Y eso tenía solución.”

It did. Most of the medication adherence problems that cardiology nurses see have solutions that are not “try harder” or “this is very important.” They are engineering problems: timing, location, information, fear management. The information that would have prevented Rosa’s eight weeks without anticoagulation was a wound-care card with a pressure protocol. The change that kept Jorge on his diuretic was a phone alarm and a bathroom map. The conversation that found Miguel’s rebound angina was one direct question about chest symptoms since stopping. None of those interventions required more than five minutes. All three required asking a question that was not on the standard checklist.

The three questions together

Miguel, Rosa, and Jorge arrived at their cardiology follow-up visits having made decisions about their medications without telling anyone on the care team. Miguel had stopped a medication for a real and valid reason — the fatigue was a genuine quality-of-life problem — but the consequence of stopping it abruptly had started something that needed to be caught. Rosa had been terrified and had made a decision in the aftermath of that terror without any preparation information she could have used. Jorge had a logistical problem with a straightforward solution that nobody had thought to ask about.

The intake assessment that finds all three patients is not a longer checklist. It is three questions that acknowledge that taking medication correctly is harder than the prescription makes it look:

“¿Está tomando todos sus medicamentos del corazón como se los recetaron — o ha habido alguno que haya dejado de tomar, o que tome diferente al que le indicaron?” Not “are you taking your medications” but “are you taking them as prescribed, or has something been different.” The word “diferente” gives the patient language for partial non-adherence without the shame of outright denial.

“¿Ha notado algo diferente en su cuerpo desde la última visita — algún síntoma nuevo, aunque parezca pequeño?” Miguel’s chest tightness was something he had noticed but categorized as the heat, not as a cardiac symptom worth mentioning. The open question that does not name the organ first invites disclosure of things the patient does not already know to report.

“¿Hay algún medicamento que le sea difícil tomar — por el horario, por cómo le hace sentir, por el costo, o por cualquier otra razón?” The word “difícil” — difficult — frames adherence as a logistical challenge rather than a moral test. Jorge’s answer was the errands and the bathroom. Rosa’s answer, if asked this at the visit where anticoagulation was started, might have been “me da miedo cortarme y no parar de sangrar.” These are not reasons to stop the medication. They are engineering problems that have engineering solutions. The nurse who asks finds them. The nurse who does not ask only finds out when the fluid is four pounds above dry weight or when it has been eight weeks without stroke protection.

Phrases referenced in this post

Practice these conversations and two hundred more clinical-Spanish scenarios at clinicalingo.com/practice, or download the free 50 essential phrases PDF for the phrases that come up in outpatient cardiology every single shift.

Related posts: Spanish for cardiology clinic nurses: post-CABG clearance, new exertional symptoms, and statin myalgia · Spanish for heart failure clinic nurses: medication barriers · Spanish for heart failure clinic nurses: between-visit phone triage · Medication reconciliation in Spanish · Spanish for telemetry nurses · How to explain a diagnosis in Spanish